Table 2. Recommended Adult Immunization Schedule by Medical Condition and Other Indications, United States, 2021
¶ = Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of past infection
§ = Recommended vaccination for adults with an additional risk factor or another indication
| = Precaution—vaccination might be indicated if benefit of protection outweighs risk of adverse reaction
^ = Delay vaccination until after pregnancy if vaccine is indicated
± = Not recommended/ contraindicated —vaccine should not be administered
• = No recommendation/ Not applicable
Vaccine | Pregnancy | Immuno-compromised (excluding HIV infection) |
HIV infection CD4 count |
Asplenia, complement deficiencies | End-stage renal disease; or on hemodialysis | Heart or lung disease, alcoholism1 |
Chronic liver disease |
Diabetes | Health care personnel2 | Men who have sex with men | |
---|---|---|---|---|---|---|---|---|---|---|---|
<2003 | ≥2003 | ||||||||||
IIV or RIV4 | 1 dose annually¶ | ||||||||||
LAIV4 |
NOT RECOMMENDED± | PRECAUTION| | 1 dose annually¶ |
||||||||
Tdap or Td | 1 dose Tdap each pregnancy¶ | 1 dose Tdap, then Td or Tdap booster every 10 yrs¶ | |||||||||
MMR | NOT RECOMMENDED*± | NOT RECOMMENDED± | 1 or 2 doses depending on indication¶ | ||||||||
VAR | NOT RECOMMENDED*± | NOT RECOMMENDED± | ^ | 2 doses¶ | |||||||
RZV | • | 2 doses at age ≥50 yrs¶ | |||||||||
HPV | NOT RECOMMENDED*± | 3 doses through age 26 yrs¶ | 2 or 3 doses through age 26 years depending on age at initial vaccination or condition¶ | ||||||||
PCV13 | • | 1¶ | dose§ | ||||||||
PPSV23 | § | 1, 2,or 3 doses depending on age¶ | and indication§ | ||||||||
HepA | § | ¶ | 2 or 3§ | doses¶ | depending on vaccine§ | ¶ | |||||
HepB | § | ¶ | 2, 3, or 4§ | doses depending on¶ | vaccine or§ | condition¶ | <60 years¶ | ¶ | |||
≥60 years^ | |||||||||||
MenACWY | 1 or 2 doses§ | depending on indication,¶ | see notes for booster recommendations§ | ||||||||
MenB | PRECAUTION| | 2 or 3 doses§ | depending on¶ | vaccine and indication, see notes for booster recommendations§ | |||||||
Hib | • | 3 doses HSCT3 recipients only¶ | § | 1¶ | dose§ |